NO902823D0 - Preparat inneholdende protein s samt fremstilling derav. - Google Patents

Preparat inneholdende protein s samt fremstilling derav.

Info

Publication number
NO902823D0
NO902823D0 NO902823A NO902823A NO902823D0 NO 902823 D0 NO902823 D0 NO 902823D0 NO 902823 A NO902823 A NO 902823A NO 902823 A NO902823 A NO 902823A NO 902823 D0 NO902823 D0 NO 902823D0
Authority
NO
Norway
Prior art keywords
preparation
containing protein
protein
content
thromboses
Prior art date
Application number
NO902823A
Other languages
English (en)
Other versions
NO902823L (no
Inventor
Hans Peter Schwarz
Ewald Molinari
Yendra Linnau
Susanne Pfeiler
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of NO902823D0 publication Critical patent/NO902823D0/no
Publication of NO902823L publication Critical patent/NO902823L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO90902823A 1989-06-26 1990-06-25 Preparat inneholdende protein s samt fremstilling derav. NO902823L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0155189A AT402153B (de) 1989-06-26 1989-06-26 Protein-s-hältige pharmazeutische präparation

Publications (2)

Publication Number Publication Date
NO902823D0 true NO902823D0 (no) 1990-06-25
NO902823L NO902823L (no) 1990-12-27

Family

ID=3515833

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90902823A NO902823L (no) 1989-06-26 1990-06-25 Preparat inneholdende protein s samt fremstilling derav.

Country Status (10)

Country Link
US (1) US5143901A (no)
EP (1) EP0406216B1 (no)
JP (1) JPH0338528A (no)
AT (2) AT402153B (no)
CA (1) CA2019745C (no)
DE (1) DE59003060D1 (no)
DK (1) DK0406216T3 (no)
ES (1) ES2061007T3 (no)
FI (1) FI94927C (no)
NO (1) NO902823L (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
US6458360B1 (en) 1990-04-25 2002-10-01 The Johns Hopkins University Soluble complement regulatory molecules
WO1993009807A1 (en) * 1991-11-18 1993-05-27 The Scripps Research Institute Methods of inhibiting thrombosis via elevation of circulating endogenous activated protein c levels
CA2143125C (en) * 1992-08-27 2008-09-23 Koenraad Mertens Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
DE4418635C2 (de) * 1994-05-27 1997-07-24 Immuno Ag Pharmazeutische Zusammensetzung zur Vorbeugung und Behandlung von Blutgerinnungsstörungen
ATE504310T1 (de) * 2000-02-04 2011-04-15 Scripps Research Inst Neuroprotektive, antithrombotische und anti- entzündliche anwendungen von aktiviertem protein c
KR20230030644A (ko) * 2020-06-29 2023-03-06 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) 항-단백질 단일-도메인 항체 및 이를 포함하는 폴리펩타이드

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258288A (en) * 1986-07-25 1993-11-02 Genzyme Corporation Vector containing DNA encoding mature human protein S
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
WO1989002747A1 (en) * 1987-10-05 1989-04-06 The American National Red Cross Therapeutic thrombolytic composition

Also Published As

Publication number Publication date
FI94927C (fi) 1995-11-27
JPH0338528A (ja) 1991-02-19
CA2019745A1 (en) 1990-12-26
DK0406216T3 (da) 1994-01-17
CA2019745C (en) 1996-12-31
ES2061007T3 (es) 1994-12-01
DE59003060D1 (de) 1993-11-18
EP0406216A3 (en) 1991-02-06
ATE95818T1 (de) 1993-10-15
US5143901A (en) 1992-09-01
EP0406216B1 (de) 1993-10-13
FI903197A0 (fi) 1990-06-26
EP0406216A2 (de) 1991-01-02
AT402153B (de) 1997-02-25
FI94927B (fi) 1995-08-15
NO902823L (no) 1990-12-27
ATA155189A (de) 1996-07-15

Similar Documents

Publication Publication Date Title
KR890011606A (ko) 항응고제
ZA908953B (en) Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
GR3006630T3 (no)
DE3853843D1 (de) Zyklisch-olefinische statische Copolymere, olefinische statische Copolymere und Verfahren zur Herstellung von zyklisch-olefinischen statischen Copolymeren.
EP0236684A3 (en) Galanthamine or analogues thereof for treating alzheimer's disease
BR9809171A (pt) Processo de tratamento de uma matéria-prima láctica, contendo gmp
DE3781854D1 (de) Verfahren und vorrichtung zur genauen untersuchung des aussehens von artikeln.
ATE78705T1 (de) Verbesserte metallhaltige pharmazeutika.
DE58904364D1 (de) Anordnung zur bestrahlung von laufenden fluessigkeiten und/oder gasen mit ultraviolett.
DE58906239D1 (de) Einrichtung zur Behandlung von Erkrankungen, insbesondere der Sehbahn.
EP0347864A3 (en) Anti-atherogenic agents
NO902823L (no) Preparat inneholdende protein s samt fremstilling derav.
DE68921908D1 (de) Zell-assoziierte Glucosyltransferase, Antikörper dagegen und eine diese enthaltende Zusammensetzung zur Prophylaxe von Karies.
FI920356A0 (fi) En biologisk preparation samt dess anvaendning.
DE68923486D1 (de) Behandlung gefährlicher Stoffe mit wässerigem Luftschaum von Polyhydroxypolymer.
NO894008D0 (no) Trekonserveringsmiddel og fremgangsmaate for behandling avtre med samme.
DK325289D0 (da) Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
HUT49411A (en) Immunologic method for detecting herbicides
BR8907500A (pt) Hidrofluoretacao catalisada de alcenos
ATE52894T1 (de) Schwarztrueffelaroma.
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
DE68900776D1 (de) Verfahren und vorrichtung zur reduzierung des feuchtigkeitsgehaltes von nassen faeden.
DE68913779D1 (de) D-Amidase und Verfahren zur Herstellung von D-alpha-Alanin und/oder L-alpha-Alaninamid.
IE830836L (en) Spiro-chroman-imidazolines
NO912823L (no) Fremgangsmaate for fremstilling av klasse ii-proteinet av neisseria meningitidis samt vaksiner som inneholder dette.